USA |NASDAQ |USD |ADR
Innate Pharma S.A (NASDAQ:IPHA) is owned by 0.45% institutional shareholders and by 0.00% insiders. The rest is owned by the public.
The largest institutional owner of Innate Pharma S.A is "Millennium Management LLC", owning 0.06% of the company's total share outstanding.
The table below contains a list of the top institutional shareholders of IPHA.
|Name||Shares||% of Shares Out||% of Total Assets Managed||Change (Shares)||Change %|
|Millennium Management LLC||46.77K||0.06%||0.00%||-2.97K||-5.97%|
|Morgan Stanley - Brokerage Accounts||36.63K||0.05%||-||-19.48K||-34.72%|
|Optiver Holding B.V.||4.49K||0.01%||-||-25.79K||-85.16%|
|Advisor Group Holdings, Inc.||1.00K||0.00%||-||-1.00K||-50.00%|
|Steward Partners Investment Advisory, LLC||650.00||0.00%||-||-650.00||-50.00%|
|LPL Financial Corp||0.00||-||-||-12.00K||-100.00%|
|Citadel Advisors Llc||0.00||-||-||-25.25K||-100.00%|
Millennium is a global alternative investment management firm, founded in 1989, which manages more than $51 billion in assets. The company seeks to pursue a diverse array of investment strategies across industry sectors, asset classes, and geographies.
The company owns 46.77K shares of Innate Pharma S.A, representing 0.06% of IPHA's total share outstanding. Using the last stock closing price of $5.29, Millennium Management LLC's current total stake in Innate Pharma S.A is worth $247.40K.
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. The company operates through Institutional Securities, Wealth Management, and Investment Management segments. As of 31 March 2021, The company’s assets under management totaled US$1.4 tillion.
The company owns 36.63K shares of Innate Pharma S.A, representing 0.05% of IPHA's total share outstanding. Using the last stock closing price of $5.29, Morgan Stanley - Brokerage Accounts's current total stake in Innate Pharma S.A is worth $193.77K.
The company owns 4.49K shares of Innate Pharma S.A, representing 0.01% of IPHA's total share outstanding. Using the last stock closing price of $5.29, Optiver Holding B.V.'s current total stake in Innate Pharma S.A is worth $23.77K.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.